Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
1,447

Quick answer

1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9138453

    Nutrient combinations for affecting an aging process

    BioMarker Pharmaceuticals, Inc. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9139620

    Feline morbillivirus and uses thereof

    THE GOVERNMENT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9138489

    Oxidized cellulose miczrospheres including visualization agents

    Covidien LP · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9139520

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9139525

    N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9139554

    Amino lipids and methods for the delivery of nucleic acids

    Tekmira Pharmaceuticals Corporation · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9139564

    2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9139598

    Glucokinase activators

    Takeda California, Inc. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9139595

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9140687

    Renal cell carcinoma biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9139827

    Polyvalent RNA-nanoparticle compositions

    Northwestern University · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9139834

    RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis

    Arrowhead Research Corporation · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9140698

    Modulating bacterial MAM polypeptides in pathogenic disease

    The Board of Regents of the University of Texas System · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9139644

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9139833

    Modified small interfering RNA molecules and methods of use

    Arrowhead Research Corporation · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9139529

    Substituted quinoxalines as sodium channel modulators

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9138416

    Sustained-release nanoparticle compositions and methods using the same

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 2015265529

    ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu Sep 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9145548

    Foot and mouth disease virus with increased stability and its use as vaccine

    The Pirbright Institute · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9145462

    Glioblastoma multiforme-reactive antibodies and methods of use thereof

    The Regents of the University of California · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9145411

    Substituted amino-pyrimidine derivatives

    Asana BioSciences, LLC · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9144557

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9144551

    Drug formulations having reduced abuse potential

    Supernus Pharmaceuticals, Inc. · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9144565

    Method for treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9144608

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9144604

    Vaccine for Shigella

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9144605

    Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region

    The Board of Regents of the University of Texas System · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9144611

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9144634

    Medical device with intrapore films

    Covidien LP · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9144615

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9145366

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9145433

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9145389

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9145552

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. TW 201536770

    Urea compounds and their use as enzyme inhibitors

    BIAL PORTELA & CA SA [PT] · Granted Thu Oct 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. MX 2015008685

    TREATMENT OF PSORIATIC ARTHRITIS USING APREMILAST.

    CELGENE CORP [US] · Granted Mon Oct 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun Sep 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9149450

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9149446

    Stabilized mutant opsin proteins

    Regents of the University of Minnesota · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9149448

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9149468

    Multicomponent crystals made ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid

    TEVA GmbH · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9149445

    Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9149437

    Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9151755

    Methods for detecting Ehrlichia infection

    Boards of Regents, The University of Texas System · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9150926

    Diagnosis and treatment of adrenocortical tumors using human microRNA-483

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9150928

    Diagnosing and monitoring CNS malignancies using MicroRNA

    The Regents of the University of California · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9150648

    Anti-ASIC1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9150600

    Triptolide prodrugs

    Regents of the University of Minnesota · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9150617

    Immunoregulatory peptides and methods of use

    Compass Therapeutics LLC · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.